All News

Found 2,358 articles

• Gene Editing Phenom CRISPR Files for $90 Million IPO

  9/12/2016

• Poseida Therapeutics Establishes Scientific Advisory Board

  9/8/2016

• The Alliance for Regenerative Medicine (ARM) Releases Agenda For 2016 Cell & Gene Meeting On The Mesa

  9/7/2016

• Horizon Discovery Ltd. And Fulcrum Therapeutics Form Collaboration For Novel CRISPR-Based Target Discovery In Genetic Diseases

  9/6/2016

• BIO Investor Forum 2016 Programming Announced

  9/6/2016

• Caribou Biosciences Appoints Vonnie Estes As Group Leader, Agricultural And Industrial Biotechnology

  8/30/2016

• Abeona Therapeutics Completes Enrollment Of Low-Dose Cohort For ABO-102 In Phase 1/2 Clinical Trial For MPS IIIA Patients

  8/29/2016

• Bayer and CRISPR Form 80 Employee Joint Venture Named Casebia Therapeutics in Boston Area

  8/22/2016

• Caribou Biosciences Develops New Method To Profile CRISPR-Cas9 Gene Editing Outcomes

  8/18/2016

• CRISPR Gene Editing Reveals New Therapeutic Approach For Sickle Cell Disease

  8/15/2016

• Synthego Launches To Bring Precision And Automation To Genome Engineering

  8/10/2016

• DECTRIS EIGER Detectors In The Fight Against Zika Virus

  8/5/2016

• Regeneron Reports Second Quarter 2016 Financial and Operating Results

  8/4/2016

• BioPharm Executive: Could It Get Any Worse?

  7/27/2016

• Former Epizyme CEO Helms Fulcrum Therapeutics; New Startup Banks $55 Million Series A

  7/19/2016

• Precision NanoSystems Launches Innovative Product To Support mRNA And CRISPR/Cas9 Therapeutic Development

  7/19/2016

• EBD Group Release: Key Life Science Industry Thought Leaders And New One-Day Programs Elevate Offerings At BioPharm America 2016

  7/15/2016

• Evotec AG Enters Licence Agreement For Access To CRISPR-CAS9 Gene Editing Technology

  7/6/2016

• First-Ever CRISPR Trial Points to Looming Problems

  6/30/2016

• Bio-Rad Release: New Method To Assess Effectiveness Of Genome-Editing Technologies

  6/30/2016